Yaning Su

Title: Yaning Su: Innovator in Pharmaceutical Compounds

Introduction

Yaning Su is a prominent inventor based in Beijing, China, known for his significant contributions to the field of pharmaceutical sciences. With a total of seven patents to his name, he has made remarkable advancements in the development of compounds that target cellular necrosis and related health conditions.

Latest Patents

Among his latest patents, Yaning Su has developed piperazine cyclic urea compounds that inhibit cellular necrosis and human receptor interacting protein 1 kinase (RIP1). These compounds include pharmaceutically acceptable salts, hydrates, and stereoisomers. His work also encompasses pharmaceutical compositions and methods for treating individuals in need, demonstrating a clear impact on improving health outcomes. Another notable patent involves difluoro phenyl amide RIP1 inhibitors, which also target cellular necrosis. This patent includes corresponding sulfonamides, prodrugs, and various forms of the compounds, emphasizing their potential in pharmaceutical applications.

Career Highlights

Yaning Su has worked at esteemed institutions such as the National Institute of Biological Sciences in Beijing and Sironax Ltd. His career reflects a commitment to advancing medical science through innovative research and development.

Collaborations

Yaning has collaborated with notable colleagues, including Zhiyuan Zhang and Xiaodong Wang, contributing to a dynamic research environment that fosters innovation.

Conclusion

Yaning Su's work in developing pharmaceutical compounds showcases his dedication to improving health through scientific innovation. His patents reflect a significant contribution to the field, highlighting the importance of research in addressing critical health issues.